We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it. via Creative Commons
Cancer drugs

New national cancer drug fund in pipeline

However, finding the finance for that fund won’t be easy, the NCCP’s director warns.

A NEW NATIONAL budget for cancer drugs will be set up before the end of this year, according to a report in the Irish Medical News today.

The new fund has identified 11 drugs – which make up around 80 per cent of current expenditure on oncology medication – which will be funded through the demand-led scheme.

The move will see control for expensive adjuvant cancer therapies removed  from hospitals.

National Cancer Control Programme (NCCP) director Dr Susan O’Reilly said that negotiations on how the fund will operate are still going on between the NCCP, the HSE and the Primary Care Reimbursement Service. She also said that financing the drugs scheme would prove difficult “because there is no new money”.

Read more about the planned fund in Paul Mulholland’s report in the Irish Medical News >

Your Voice
Readers Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.